Journals / European Archives of Medical Research / 2020 / Cilt: 36 - Sayı: 4

Impact of Canalith Repositioning Maneuver with or Without Vestibular Suppressant Therapy on Anxiety Levels among Patients with Benign Paroxysmal Positional Vertigo

Pages
267–271
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

STAI-S and STAI-T scores substantially decreased within the groups after the treatment; in other words, both CRM and M + VST had lower scores after the treatment regimens (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Many studies do not recommend vestibular suppressant as an adjunctive therapy to canalith repositioning maneuver (CRM); nevertheless, it has been proven that those treatment regimens may alter the natural course of treatment by lowering both the anxiety effect and an additive placebo effect.
📊
Key Findings & Data:Before the therapy, each participant received a 40-item STAI test, and then the select treatment was applied.
💡
Conclusion & Impact:STAI-S and STAI-T scores substantially decreased within the groups after the treatment; in other words, both CRM and M + VST had lower scores after the treatment regimens (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Many studies do not recommend vestibular suppressant as an adjunctive therapy to canalith repositioning maneuver (CRM); nevertheless, it has been proven that those treatment regimens may alter the natural course of treatment by lowering both the anxiety effect and an additive placebo effect. Therefore, we aimed to look for and compare the efficacy of CRM therapy alone with maneuver (M) + vestibular suppressant therapy (M + VST). As a novelty, we used the State-Trait Anxiety Inventory (STAI) to express both the current and underlying anxiety level of the susceptible cases. Methods: One hundred cases were included in the study and were randomly assigned to either CRM or M + VST groups. Before the therapy, each participant received a 40-item STAI test, and then the select treatment was applied. On the second week, the participants were reevaluated and filled in another STAI. Results: In CRM, 23 cases were affected from the right side and 27 from the left side. Further, 21 cases received the barbeque M and 29 the Epley maneuver. On the other hand, in M + VST, 19 cases were affected from the right side and 31 from the left side. In addition, 27 cases received the barbeque M and 23 the Epley maneuver. The STAI-State (S) and STAI-Trait (T) results were compared before and after the treatment regimens. Pretreatment scores of STAI-S or STAI-T were not significant between the two groups (p=0.494; p=0.481). STAI-S and STAI-T scores substantially decreased within the groups after the treatment; in other words, both CRM and M + VST had lower scores after the treatment regimens (p

🔖

Cite This Article

GÜRPINAR, B., TUTAR, B., BERKİTEN, G., KUMRAL, T. L., UYAR, Y. (2022). Impact of Canalith Repositioning Maneuver with or Without Vestibular Suppressant Therapy on Anxiety Levels among Patients with Benign Paroxysmal Positional Vertigo. European Archives of Medical Research, Cilt: 36 - Sayı: 4, 267–271. https://ajindex.com/articles/510366

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tang H, Li W. Advances in the diagnosis and treatment of benign paroxysmal positional vertigo. Exp Ther Med 2017;14:2424-30
  2. Hagr A. Comorbid psychiatric conditions of benign paroxysmal positional vertigo. Int J Health Sci (Qassim) 2009;3:23-8
  3. Spielberger CD, Sydeman SJ. State-Trait Anxiety Inventory and State-Trait Anger Expression Inventory. In: The and outcome assessment. Mark Edward, editors. Hillsdale, NJ: Lawrence Erlbaum Associates; 1994 p. 292-321
  4. Ferrari S, Monzani D, Baraldi S, Simoni E, Prati G, Forghieri M, et al. Vertigo “in the pink”: The impact of female gender on psychiatricpsychosomatic comorbidity in benign paroxysmal positional vertigo patients. Psychosomatics 2014;55:280-8
  5. Urbaniak GC, Plous S. Research Randomizer (Version 4.0) [Computer software]. Last accessed date: 22.06.2013. Available from: http://www. randomizer.org/ 6. Epley JM. The canalith repositioning procedure for treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 1992;107:399-404
  6. Semont A, Freyss G, Vitte E. Curing the BPPV with a liberatory maneuver. Adv Oto-Rhino-Laryng 1988;42:290-3
  7. İnan HC, Kıraç M. An Evaluation of the Effects of betahistine and dimenhydrinate on posterior canal benign paroxysmal positional vertigo. Turk Arch Otorhinolaryngol 2019;57:191-6
  8. Bhattacharyya N, Gubbels SP, Schwartz SR, Edlow JA, El-Kashlan H, Fife T, et al. Clinical practice guideline: benign paroxysmal positional vertigo (update). Otoolaryngol Head Neck Surg 2017;156:S1-47
  9. Eagger S, Luxon L, Davies R, Coelho A, Ron M. Psychiatric morbidity in patients with peripheral vestibular disorder: a clinical and neurootological study. J Neurol Neurosurg Psychiatry 1992;55:383-7
  10. Mckenna L, Hallam RS, Hinchcliffef R. The prevalence of psychological disturbance in neuro-otology outpatients. Clin Otolaryngol Allied Sci 1991;16:452-6
  11. Yardley L. Overview of psychologic effects of chronic dizziness and balance disorders. Otolaryngol Clin North Am 2000;33:603-16
  12. Yardley L, Verschuur C, Masson E, Luxon L, Haacke N. Somatic and psychological factors contributing to handicap in people with vertigo. Br J Audiol 1992;26:283-90
  13. Yardley L, Luxon L, Haacke NP. A longitudinal study of symptoms, anxiety and subjective well-being in patients with vertigo. Clin Otolaryngol Allied Sci 1994;19:109-16
  14. Nagarkar AN, Gupta AK, Mann SBS. Psychological findings in benign paroxysmal positional vertigo and psychogenic vertigo. J Otolaryngol 20